Here's Why We're Watching Intellia Therapeutics' (NASDAQ:NTLA) Cash Burn Situation [Yahoo! Finance]
Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Intellia Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to Nexiguran Ziclumeran (nex-z) for the Treatment of Hereditary Transthyretin (ATTR) Amyloidosis with Polyneuropathy [Yahoo! Finance]
Intellia Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to Nexiguran Ziclumeran (nex-z) for the Treatment of Hereditary Transthyretin (ATTR) Amyloidosis with Polyneuropathy
Down 33% in 1 Month, Should You Buy the Dip With Intellia Therapeutics Stock? [Yahoo! Finance]